Actions

3 biotech actions to reinvent mental health treatment

3 biotech actions to reinvent mental health treatment

Mental health issues are a growing concern in the United States. According to the National Institute of Mental Health (NIMH), almost 20% of adults, or 43 million people, suffer from some form of mental illness each year. Conditions can range from mild states like depression and anxiety to more serious conditions like dementia, bipolar disorder, …

3 biotech actions to reinvent mental health treatment Read More »

Spotlight on Recent Federal Regulatory Actions |  IFT

Spotlight on Recent Federal Regulatory Actions | IFT

CMS’s proposed rule to streamline eligibility processes in Medicaid and the Children’s Health Insurance Program (“CHIP”) and the solicitation of public comments on the creation of a national provider database impacts states, payers and providers. To inform the development of public comment, this article summarizes the main elements of these recent agency publications. Medicaid Eligibility …

Spotlight on Recent Federal Regulatory Actions | IFT Read More »